His primary scientific interests are in Immunology, Antigen, Immune system, Cell biology and Cancer research. His work on Immunology deals in particular with Antigen-presenting cell, Dendritic cell and MHC class I. His Antigen-presenting cell research focuses on Interleukin 12 and how it relates to Interleukin 21 and T cell.
His research in Antigen intersects with topics in Immunity and Follicular dendritic cells. His Immune system research integrates issues from MUC1, Secretion and Breast cancer. His Cell biology research incorporates elements of Heat shock protein, Molecular biology, Transcription factor and Autocrine signalling.
His primary areas of study are Immunology, Antigen, Cancer research, Cytotoxic T cell and Dendritic cell. His study ties his expertise on Cancer together with the subject of Immunology. His Antigen research is multidisciplinary, incorporating perspectives in Cell fusion, Immune system and Cell biology.
His work focuses on many connections between Cancer research and other disciplines, such as Oncogene, that overlap with his field of interest in Carcinogenesis and Mammary tumor. His Cytotoxic T cell study integrates concerns from other disciplines, such as Ovarian carcinoma and T cell. His research investigates the connection with Antigen-presenting cell and areas like CD40 which intersect with concerns in Natural killer T cell.
Jianlin Gong focuses on Cancer research, Cell biology, Immune system, Antigen and Immunology. His biological study spans a wide range of topics, including Cancer cell, Cell, Cell cycle, Cancer and Chemoimmunotherapy. His work deals with themes such as Receptor and Antigen presentation, which intersect with Cell biology.
His Receptor research includes themes of Extracellular and Heat shock protein. His research investigates the link between Antigen and topics such as Cell fusion that cross with problems in Immunotherapy, Immunogenicity, Follicular dendritic cells, Antigen-presenting cell and CD40. His studies in Immunology integrate themes in fields like Cytotoxic T cell and Wilms' tumor.
The scientist’s investigation covers issues in Cancer research, Cancer cell, Cell cycle, Transcription factor and Cell biology. In his study, which falls under the umbrella issue of Cancer research, Immunology and Chemotherapy is strongly linked to Cancer. His Cancer cell research is multidisciplinary, incorporating elements of Heat shock factor, Regulation of gene expression, HSF1 and Gene knockdown.
His Cell biology study combines topics from a wide range of disciplines, such as Receptor, Secretion, Immunity and Antigen. The Antigen study combines topics in areas such as Heat shock protein and Immune system. Jianlin Gong studies MHC class I which is a part of Immune system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses.
David Avigan;Baldev Vasir;Jianlin Gong;Virginia Borges.
Clinical Cancer Research (2004)
Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells
Jianlin Gong;Dongshu Chen;Masahiro Kashiwaba;Yongqing Li.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Interaction of Glycogen Synthase Kinase 3β with the DF3/MUC1 Carcinoma-Associated Antigen and β-Catenin
Yongqing Li;Ajit Bharti;Dongshu Chen;Jianlin Gong.
Molecular and Cellular Biology (1998)
Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity.
Jianlin Gong;Najmosama Nikrui;Dongshu Chen;Shigeo Koido.
Journal of Immunology (2000)
Induction of Antitumor Immunity by Vaccination of Dendritic Cells Transfected with MUC1 RNA
Shigeo Koido;Masahiro Kashiwaba;Dongshu Chen;Sandra Gendler.
Journal of Immunology (2000)
Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells
Jianlin Gong;David Avigan;Dongshu Chen;Zekui Wu.
Proceedings of the National Academy of Sciences of the United States of America (2000)
Heat Shock Proteins Promote Cancer: It's a Protection Racket
Stuart K. Calderwood;Jianlin Gong.
Trends in Biochemical Sciences (2016)
Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cells
Claude D. Gimmi;Briggs W. Morrison;Brigitte A. Mainprice;John G. Gribben.
Nature Medicine (1996)
Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity.
Stuart K. Calderwood;Stuart K. Calderwood;Jimmy R. Theriault;Jianlin Gong.
European Journal of Immunology (2005)
mTOR Is Essential for the Proteotoxic Stress Response, HSF1 Activation and Heat Shock Protein Synthesis
Shiuh-Dih Chou;Thomas Prince;Jianlin Gong;Stuart K. Calderwood.
PLOS ONE (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: